ATE194618T1 - Als immunosuppressiva nützliche trans- cyclopentanylpurinanaloge - Google Patents

Als immunosuppressiva nützliche trans- cyclopentanylpurinanaloge

Info

Publication number
ATE194618T1
ATE194618T1 AT92120653T AT92120653T ATE194618T1 AT E194618 T1 ATE194618 T1 AT E194618T1 AT 92120653 T AT92120653 T AT 92120653T AT 92120653 T AT92120653 T AT 92120653T AT E194618 T1 ATE194618 T1 AT E194618T1
Authority
AT
Austria
Prior art keywords
trans
immunosuppressants
cyclopentanyl
hydrogen
purine analogues
Prior art date
Application number
AT92120653T
Other languages
English (en)
Inventor
David R Borcherding
Ronald E Esser
Carl K Edwards Iii
Douglas L Cole Iii
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE194618T1 publication Critical patent/ATE194618T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT92120653T 1991-12-06 1992-12-03 Als immunosuppressiva nützliche trans- cyclopentanylpurinanaloge ATE194618T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80415391A 1991-12-06 1991-12-06
US96560192A 1992-11-02 1992-11-02

Publications (1)

Publication Number Publication Date
ATE194618T1 true ATE194618T1 (de) 2000-07-15

Family

ID=27122672

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92120653T ATE194618T1 (de) 1991-12-06 1992-12-03 Als immunosuppressiva nützliche trans- cyclopentanylpurinanaloge

Country Status (17)

Country Link
EP (1) EP0545413B1 (de)
JP (1) JP3264289B2 (de)
KR (1) KR100251996B1 (de)
AT (1) ATE194618T1 (de)
AU (1) AU658698B2 (de)
CA (1) CA2084222C (de)
DE (1) DE69231242T2 (de)
DK (1) DK0545413T3 (de)
ES (1) ES2149163T3 (de)
FI (1) FI109026B (de)
GR (1) GR3034586T3 (de)
HU (2) HU9203858D0 (de)
IL (1) IL103962A (de)
MX (1) MX9206963A (de)
NO (1) NO305207B1 (de)
NZ (1) NZ245342A (de)
PT (1) PT545413E (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI956142A7 (fi) 1993-06-21 1995-12-20 Merrell Pharma Inc Uudet proinflammatoristen sytokiinien selektiivisinä inhibiittoreina k äyttökelpoiset karbosykliset nukleosidiaineet
TW552261B (en) * 1996-07-03 2003-09-11 Japan Energy Corp Novel purine derivative
US6413974B1 (en) 1998-02-26 2002-07-02 Aventis Pharmaceuticals Inc. 6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
US6479487B1 (en) 1998-02-26 2002-11-12 Aventis Pharmaceuticals Inc. 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
FR2793794B1 (fr) * 1999-05-21 2001-07-27 Hoechst Marion Roussel Inc Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
US6861524B2 (en) 2000-10-31 2005-03-01 Aventis Pharmaceuticals Inc. Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038479A (en) * 1969-11-17 1977-07-26 Burroughs Wellcome Co. Amino purine derivatives
US4076711A (en) * 1976-04-05 1978-02-28 Schering Corporation Triazolo [4,5-d]-pyrimidines
CA2001715C (en) * 1988-11-14 1999-12-28 Muzammil M. Mansuri Carbocyclic nucleosides and nucleotides
EP0465297B1 (de) * 1990-07-04 1996-01-31 Merrell Dow Pharmaceuticals Inc. 9-Purinyl-Phosphonsäurederivate
AU647822B2 (en) * 1990-09-14 1994-03-31 Marion Merrell Dow Inc. Novel carbocyclic adenosine analogs useful as immunosuppressants

Also Published As

Publication number Publication date
EP0545413A1 (de) 1993-06-09
HU217077B (hu) 1999-11-29
IL103962A (en) 1997-01-10
GR3034586T3 (en) 2001-01-31
JPH0656835A (ja) 1994-03-01
NO305207B1 (no) 1999-04-19
CA2084222C (en) 2004-04-06
FI109026B (fi) 2002-05-15
DE69231242T2 (de) 2000-12-21
KR100251996B1 (ko) 2000-09-01
HU9203858D0 (en) 1993-03-29
NO924691L (no) 1993-06-07
EP0545413B1 (de) 2000-07-12
AU658698B2 (en) 1995-04-27
NO924691D0 (no) 1992-12-04
CA2084222A1 (en) 1993-06-07
FI925520A0 (fi) 1992-12-04
ES2149163T3 (es) 2000-11-01
AU2975292A (en) 1993-06-10
DK0545413T3 (da) 2000-10-09
FI925520L (fi) 1993-06-07
NZ245342A (en) 1995-10-26
PT545413E (pt) 2000-10-31
JP3264289B2 (ja) 2002-03-11
IL103962A0 (en) 1993-05-13
HUT62896A (en) 1993-06-28
DE69231242D1 (de) 2000-08-17
MX9206963A (es) 1993-06-01

Similar Documents

Publication Publication Date Title
DE69324923D1 (de) Antiretrovirale, enantiomere Nukleotid-Analoge
PT1381366E (pt) Derivados indole, azaindole e heterocíclicos relacionados de amidopiperazina
FI935151A0 (fi) Foerfaranden foer diastereoselektiv syntes av nukleosider
DK0534709T3 (da) Substituerede taxaner som anti-tumormidler
ATE144513T1 (de) Pyrrolopyrimidinderivate, ihre herstellung und verwendung
MXPA04001240A (es) Analogos antitumorales.
HUP0001760A2 (hu) Aril-acil-piridazin-származékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és a vegyületek alkalmazása gyógyszerkészítmények előállítására
SE8500307D0 (sv) Nya, antiviruella medel
CA2051012A1 (en) Carbocyclic adenosine analogs useful as immunosupressants
ATE110382T1 (de) Oxetanocin.
FR2389623A1 (de)
ATE194618T1 (de) Als immunosuppressiva nützliche trans- cyclopentanylpurinanaloge
ATE34394T1 (de) Therapeutisch aktive di-, tri-, tetra- und penta- aza-indene.
DE69509182D1 (de) Herstellung N-9-substituierter Guanin-Verbindungen
GB2233558B (en) Psychotropic use of aromatic amines
HUP9701134A2 (hu) Új kumarinszármazékok, eljárás előállításukra és intermedierként való alkalmazásuk új gyógyhatású kumarinszármazékok előállítására
ATE139444T1 (de) Carbocyklische nukleosidanaloge als immunsuppressoren
BG60248B2 (en) Process for the preparation of phenoxyethylamine derivatives
FI943360L (fi) Propoksibentseenijohdannaisia

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee